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Abstract
Background: Hepatic cirrhosis is a common pathway of progressive liver destruction from multiple causes. Iron uptake can
occur within the hepatic parenchyma or within the various nodules that form in a cirrhotic liver, termed siderotic nodules.
Siderotic nodule formation has been shown to correlate with inflammatory activity, and while the relationship between
siderotic nodule formation and malignancy remains unclear, iron distribution within hepatic nodules has known
implications for the detection of hepatocellular carcinoma. We aimed to evaluate the role of abdominal susceptibility-
weighted imaging in the detection of siderotic nodules in cirrhotic patients.
Methodology/Principal Findings: Forty-six (46) cirrhotic patients with at least one siderotic nodule detected on previous
imaging underwent both computed tomography and magnetic resonance imaging (T1-, T2-, T2*-, and susceptibility-
weighted imaging) at 3.0 Tesla. Imaging data was independently analyzed by two radiologists. Siderotic nodule count was
determined for each modality and imaging sequence. For each magnetic resonance imaging technique, siderotic nodule
conspicuity was assessed on a 3 point scale (1=weak, 2=moderate, 3=strong). More nodules were detected by
susceptibility weighted imaging (n=2935) than any other technique, and significantly more than by T2* weighted imaging
(n=1696, p,0.0001). Lesion conspicuity was also highest with susceptibility-weighted imaging, with all nodules found to
be moderate (n=6) or strong (n=40); a statistically significant difference (p,0.001).
Conclusions: Susceptibility-weighted imaging had the greatest lesion conspicuity and detected the highest number of
siderotic nodules suggesting it is the most sensitive imaging technique to detect siderotic nodules in cirrhotic patients.
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Introduction
Iron is a critical element for human life, and the majority of
human iron exists in heme-based proteins (predominantly
hemoglobin) or ferritin, an iron storage protein. The liver is the
primary organ for iron storage and metabolism. Numerous human
diseases are associated with abnormalities of iron metabolism, and
in the liver, the pathogenesis of many hepatic diseases result in the
accumulation of excess hepatic iron. Excess hepatic iron can result
from genetic predisposition (hemochromatosis) or from excess
circulating iron, which is typically due to excess breakdown of
hemoglobin (hemosiderosis). Many techniques have been de-
veloped to detect and quantify hepatic iron content because of its
importance in the diagnosis and prognosis of related diseases and
for monitoring and evaluating treatment response. The quantifi-
cation of iron content is most commonly indirectly estimated by
serum ferritin level and directly determined by liver biopsy.
However, ferritin measurements often do not accurately reflect
hepatic iron stores [1,2]. Liver biopsy is invasive, entails risks with
repeated use, samples only a small portion of the liver, and is not
an option in all patients [3–5]. Biopsy is also problematic, as iron
distribution is often inhomogeneous, particularly in diseased livers.
As a result of these issues, and with improvements in imaging
technology, T2* mapping with MRI has become a viable method
for estimating iron concentration within the liver [6].
Hepatic nodules can be detected with ultrasound, computed
tomography (CT), or magnetic resonance (MR) imaging. Ultra-
sound lacks the ability to discriminate iron content, and the
sensitivity of computed tomography for the detection of iron is also
limited [7]. MR T2* weighted imaging, on the other hand, is
considered to be the most sensitive technique for the visualization
of iron-containing hepatic nodules, while T2* mapping methods
can be used to quantify diffuse hepatic iron concentration.
Susceptibility-weighted imaging (SWI) is more sensitive to
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addition to T2* contrast. It has been well documented in the brain
that SWI is superior to T2* and other existing MRI techniques for
the detection of iron content, hemorrhage, and calcification [8,9].
This is because phase data is an additional source of information
about local susceptibility changes induced by iron, calcium or
deoxyhemoglobin in various physiological or pathological condi-
tions. For example, SWI can detect as many as 5 times more
cerebral hemorrhagic lesions in patients with diffuse axonal injury
than conventional T2* weighted imaging [10].
Hepatic cirrhosis is the progressive destruction of normal
hepatic architecture with fibrosis and replacement by a range of
partially restorative nodules, varying from benign regenerative
nodules and premalignant dysplastic nodules to hepatocellular
carcinoma. Even in the absence of systemic iron storage diseases
such as hemochromatosis, iron can accumulate within regenera-
tive or dysplastic nodules in the cirrhotic liver; these nodules are
termed ‘‘siderotic nodules’’ (SN) [11]. While the mechanism of
iron deposition (siderosis) within reticuloendothelial cells by
mobilized iron from damaged hepatocytes in systemic iron storage
diseases has been characterized, the process of siderotic nodule
formation remains uncertain though both active viral replication
and transferrin receptor abnormalities are thought to play a role
[12–14]. Though only a small percentage of siderotic nodules are
dysplastic, approximately 25% of all dysplastic nodules (DN) are
also siderotic nodules [15,16]. Moreover, dysplastic SN are pre-
malignant lesion while regenerative SN are markers for severe
viral or alcoholic cirrhosis. Therefore, the diagnosis of siderosis is
clinical important. The relationship of hepatic iron deposition to
hepatic fibrosis, cirrhosis and neoplasia is also not fully understood
[17,18]. Magnetic resonance imaging is currently unable to
differentiate siderotic regenerative nodules from siderotic dysplas-
tic nodules [19]. The association of siderotic nodules and
malignancy remains controversial; some studies reported no
increase in dysplastic nodules or hepatocellular carcinoma in
patients with siderotic nodules [15,20] but others have reported
that siderotic nodules can be precursors of primary hepatocellular
carcinomas in patients with chronic liver diseases [21–23], and
that the incidence of hepatocellular carcinomas is higher in
patients with iron-containing nodules than in those without iron-
containing nodules [23]. Iron-free foci were found in siderotic
macroregenerative nodules in liver cirrhosis, and these foci were
classic and overt carcinoma or borderline lesions showing an
expansive growth pattern [15]. Furthermore, the displacement of
iron within a nodule by tumor is an established method for the
early detection of HCC [16,21,24]. Therefore, the diagnosis of
siderosis, siderotic nodules, and iron-free nodules in the cirrhotic
liver are clinically relevant for the detection of hepatocellular
carcinoma.
T2*-weighted imaging is currently the most sensitive MRI
technique to detect siderotic nodules in the liver with a reported
80% sensitivity and 95% specificity [19]. A sensitive and
noninvasive technique could also help answer questions regarding
the iron involvement in the development of hepatocellular
carcinoma (HCC) by monitoring iron content in multistep human
HCC: from low-grade dysplastic nodule, to high-grade dysplastic
nodule, early HCC, well-differentiated HCC, nodule-to-nodule
HCC, and finally, to moderately differentiated HCC [25,26].
Technical limitations have previously precluded the use of SWI in
the abdomen; however, with the recent availability of a multislice
2D breath-hold technique, abdominal SWI has become feasible
[27]. The goal of this study is to evaluate whether abdominal SWI
allows greater sensitivity for the detection of siderotic nodules than




All research procedures were approved by the Institutional
Review Board of the Third Medical Military University and were
conducted in accordance with the Declaration of Helsinki. Written
informed consent was obtained for all patients.
Participants
Using an institutional database, a total of 362 patients from
December 2009 to December 2010 with clinically diagnosed
cirrhosis were identified. From this set of identified patients, 46
patients (29 men, 17 women, mean age: 47 years, range: 28–76
years) agreed to participate in our study and have a specialized set
of CT and MR examinations. Patient inclusion was contingent
upon meeting the following criteria: 1) ability to sustain a 20
second breath hold; 2) no evidence of iron overload (e.g.,
hemochromatosis or hemosiderosis); 3) at least one siderotic
nodule previously detected by CT or MR; and 4) no other lesions,
such as cholangiocarcinoma, detected by prior MR or CT;
however, patients with hepatocellular carcinoma were included in
the study. Of the 46 patients, causes of cirrhosis were hepatitis B
(n=37, 80.4%), hepatitis C (n=5, 10.9%), autoimmune cirrhosis
(n=2, 4.3%), alcohol abuse (n=1, 2.2%), and primary biliary
cirrhosis (n=1, 2.2%).
Computed Tomographic Imaging
All subjects were imaged with dual-source CT (Definition,
Siemens Healthcare, Forchheim, Germany). Imaging parameters
were: 250 mAs, 120 kVp, 1.2 mm beam collimation with a 0.5 s
gantry rotation time. Field of view (FOV) was 35 cm, with
a reconstruction thickness and interval both of 5 mm. No oral
contrast was administered. The examination consisted of non-
contrast images followed by three dynamic images acquired 35 s
(hepatic arterial phase), 70 s (portal venous phase), and 180 s
(delayed phase) acquired following the intravenous administration
of 100–120 ml Ultravist 370 (Bayer-Schering, Leverkusen, Ger-
many) at a rate of 3–4 ml/s.
Magnetic Resonance Imaging
MR imaging for all subjects was performed on a 3.0 T whole-
body system (Magnetom Trio, Siemens Healthcare, Erlangen,
Germany) using a standard 12-channel matrix coil, without
intravenous contrast enhancement. The following MR pulse
sequences were used for all patients: transverse T1-weighted 2D
gradient echo (GRE) (flip angle 70u, TR/TE 140/2.46 ms),
transverse T2-weighted 2D fast spin echo (flip angle 122u, TR/
TE=3700/84 ms, ETL 9), transverse T2*-weighted 2D GRE (flip
angle 20u, TR/TE=150/10 ms) and transverse abdominal 2D
SWI (flip angle 20u, TR/TE=150/10 ms). For all sequences,
FOV was 2806285 mm
2 and matrix was 320–384 6 250; slice
thickness was 5 mm with a gap of 1 mm. Depending upon the
liver size, two to three breath holds of 15 to 20 s duration were
used for each sequence.
For abdominal SWI, a recently developed multislice 2D GRE
sequence with SWI reconstruction (Siemens work-in-progress
sequence #608, Siemens Healthcare, Erlangen, Germany) was
used. An SWI dataset consisted of 3 contiguous 10-slice transverse
acquisitions through the liver, with the duration of each
acquisition suitable for a single breath-hold (less than 20 s).
Siderotic Nodule Detection in Cirrhosis with SWI
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magnet. Postprocessing of abdominal SWI images was designed
to reduce motion artifacts from breathing and cusp artifact (also
termed singularity artifact) from B0 inhomogeneity, both of which
are increased in abdominal imaging compared to brain imaging.
First, complex images from each of the 12 channels were acquired
individually and high-pass filtered with a 32632 filter to reduce
artifacts related to both coil sensitivity and magnetic field
inhomogeneity. High-pass filtering was achieved by the following
steps: 1) Fourier transformation of the complex image to k-space;
2) while keeping the center of k-space (size 32632) unchanged, the
remainder of the k-space matrix was zero-filled; 3) inverse Fourier
transform of the zero-filled k-space to obtain a complex low-pass
filter, and division of the original complex image with this low-pass
filter to remove low spatial frequency components. Then, the high-
pass filtered complex images from each channel were weighted by
the coil sensitivity factor and combined to generate a single
complex image, as described by the adaptive combine method
[28]. The phase image from this final channel-combined complex
image was extracted and used to create a positive phase mask such
that the mask value would be ( p{ q)= p for phase .0 and be 1
otherwise. Finally, the SWI image was created by multiplying this
phase mask four times to the magnitude image [29]. The main
difference between this process and brain SWI [29] is the filtering
of the multichannel data prior to recombination. Additionally,
SWI parameters such as resolution, flip angle (the main de-
terminant of contrast in magnitude images), and echo time (main
determinate of contrast for phase images) were evaluated to
determine the optimal experimental parameters for hepatic
imaging in a typical clinical setting.
Image Analysis
Nodules that were hyperattenuating compared to background
parenchyma were considered to represent siderotic nodules on
CT, and nodules that were hypointense to background parenchy-
ma were considered to represent SN on MRI [22,30]. Because of
the large numbers and small sizes of these nodules, it was not
feasible to evaluate all images and all imaging sequences by
enumerating SN in the entire liver. By reader consensus, a single
representative slice was first chosen from the T2*-weighted GRE
dataset that contained the largest number of SN; then,
corresponding slices which matched or most closely matched the
representative slice were chosen from the T1-weighted, T2-
weighted, SWI, and CT datasets by comparing the position of the
liver.
After the combined representative dataset was created for each
patient, two readers independently reviewed all 92 (46 MRI, 46
CT) examinations on a commercially available imaging worksta-
tion (Syngo, Siemens Medical Solutions). Readers were blinded to
previous clinical MR interpretations, pathologic results, and
sequences used. For each of the representative slices, the number
of SN was determined and the distribution classified as focal (,5
Figure 1. Total number of siderotic nodules (SN) detected by imaging technique for both readers. The total number of siderotic nodules
detected by imaging for all patients by two independent readers. Different imaging methods are represented on the horizontal axis. The number of
detected siderotic nodules is represented on the vertical axis. Light gray: results for reader 1. Dark gray: results for reader 2.
doi:10.1371/journal.pone.0036454.g001
Table 1. Number of siderotic nodules (SN) detected by all tested imaging techniques.
Parameter CT T1-weighted imaging T2-weighted imaging T2*-weighted imaging SWI
1
Mean Count
{ 0.560.2 2.161.7 12.266.6 36.9615.4 63.8619.7
P-value
{ ,0.0001 ,0.0001 ,0.0001 ,0.0001 -
{The mean value for both readers are listed 6 standard errors of the mean for all patients.
{P-values were calculated using paired t-tests between SWI and each other imaging technique.
1SWI: susceptibility-weighted imaging, a 2D-gradient echo based abdominal imaging technique.
doi:10.1371/journal.pone.0036454.t001
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slice). For any questionable nodule, consensus review with a third
reader was used to decide. Any nodule detected on CT with an
attenuation value $100 Hounsfield units was considered to
represent a calcified lesion and was excluded for SN analysis
[31]. For MR images, the conspicuity of SN was calculated based
on the ratio of SN signal intensity to background parenchyma and
graded on a 1 to 3 scale: grade 1 (low conspicuity), .0.7; grade 2
(moderate conspicuity), conspicuity ratios 0.4 and 0.7; grade 3
(high conspicuity), conspicuity ratio ,0.4.
Statistical Analysis
All statistics were computed using dedicated statistical software
(SPSS version 13.0, SPSS Inc., Chicago, Illinois). P values of
,0.05 were considered statistically significant. The number,
distribution, and conspicuity of SN were compared by paired t-
test. Cohen’s kappa method was used to assess inter-reader
agreement with respect to diagnosis determined by each reader on
the basis of images of different imaging techniques. The reported
Cohen K is the average K values computed for both readers over
the entire set of all images.
Results
The comparison of SN detected by CT, T1-, T2-, T2*-weighted
and SWI imaging is illustrated in Figure 1, for both independent
readers. Using reader averages, the number of SN per patient
ranged from 0 to 3.5 for CT images, 0 to 13.5 for T1-weighted
images, 0 to 80.5 for T2-weighted images, 5 to 199 for T2*-
weighted images, and 8 to 305 for SWI. The average number of
SN detected for all patients was significantly greater on SWI
images than on any other imaging technique (p,0.0001); refer to
Table 1. An example showing the number and conspicuity of
nodules seen with T2* and SWI compared to other techniques is
shown in Figure 2. There was no single case where SWI detected
fewer SN than any other imaging technique. In this study, SN
were detected by T2*-weighted and SWI imaging in each patient.
Using averaged reader results, however, SN could not be detected
by CT in 75% (34.5/46) of patients, by T1-weighted imaging in
55% (25.5/46) of patients, and T2-weighted imaging in 22% (10/
46) of patients (Table 2). Nodule distribution varied by technique.
According to the nodule distribution classification, more patients
were classified as diffuse 77% (35.5/46) by SWI, while T2* GRE
demonstrated a diffuse distribution of nodules in 13% (6/46) of
patients (Table 2).
Overall conspicuity of SN was categorized for each MR
imaging technique (Table 3). Lesion conspicuity was lowest with
T1-weighted imaging and greatest with SWI. Conspicuity was
found to be significantly different between every pair of techniques
(p,0.001). Compared to T2*-weighted imaging, SN detected with
SWI had superior contrast (lesions appeared more hypointense to
background hepatic parenchyma) and visibility (Fig. 3). Nearly all
(87%, 40/46) patients were given a conspicuity grade of 3 (the
highest) on SWI, compared to 26% (12/46) for T2*-weighted
imaging. Similarly, no patients were considered to have grade 1
conspicuity on SWI imaging, whereas 14% (6.5/46) were
considered grade 1 on T2*-weighted images. Because conspicuity
on CT has a different definition than that from MR images,
conspicuity of SN on CT images was not included in the
comparison.
Inter-reader correlation for conspicuity, determined using the K
coefficient, was estimated at 0.82 based on results provided by
each individual reader.
Figure 2. Representative images from a single patient com-
paring CT and multiple MR imaging methods. A 37 year-old man
with hepatitis-B induced cirrhosis. (a) CT image demonstrates a high-
attenuation siderotic nodule in the gallbladder fossa (black arrow). (b)
Transverse T1-weighted gradient echo image and (c) Transverse T2-
weighted fast spin echo image with a few hypointense nodules. (d)
Transverse T2*-weighted GRE image demonstrated numerous hypoin-
tense nodules with different sizes (long arrows). (e) Transverse
susceptibility weighted image (SWI) shows a greater number of
hypointense lesions, with a higher contrast relative to background
parenchyma (short arrows). (f) SWI comparison image from a normal 37-
year-old man.
doi:10.1371/journal.pone.0036454.g002
Table 2. Siderotic Nodule (SN) Distribution.
Nodule
Distribution CT T1-weighted imaging T2-weighted imaging T2*-weighted imaging SWI
{
focal 11.560.7 17.560.7 29.562.1 18.562.1 0
scattered 0 362.8 6.562.2 21.563.5 10.562.1
diffuse 0 0 0 661.4 35.562.1
Nodule distribution was classified as focal (,5 per slice), scattered (5–20 per slice), or diffuse (.20 per slice). The average number of patients and its standard deviation
in each level determined by two readers are listed.
{SWI: susceptibility-weighted imaging, a 2D-gradient echo based abdominal imaging technique.
doi:10.1371/journal.pone.0036454.t002
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Our results of this study evaluating 46 patients with hepatic
cirrhosis and siderotic nodules demonstrated that abdominal SWI
detects more nodules than other tested sequences; in particular,
almost six times as many patients (35.5 vs. 6, using averaged reader
statistics, Table 2) were categorized as having diffuse SN (.20
nodules per slice) than T2*-weighted images with long echo times
(TE), the current standard. Not only was SWI able to detect more
lesions, but SWI also demonstrated significantly better lesion
conspicuity than other tested sequences. These findings suggest
that SWI has a greater sensitivity for the detection of SN than T2*-
weighted imaging, likely due to the improved sensitivity for the
detection of iron content. At 3T, both SWI and T2*-weighted
images have an echo time of 10 ms; which is equivalent to an echo
time of 20 ms at 1.5T when considering susceptibility effects. T2*-
weighted demonstrates 80% sensitivity for SN detection at 1.5 T,
and longer echo times (e.g., 15 ms at 1.5T) may further increase
sensitivity [17,22]. Increased conspicuity on SWI images can be
explained by the enhancement of susceptibility effects when using
processed phase information in combination with magnitude
images. Previous theoretical work has indicated that even an
object measuring less than 25% of a voxel can have a conspicuous
appearance if sufficiently paramagnetic [32].
Improved detection of siderotic nodules has possible clinical uses
and opens up new potential avenues for research, such as
evaluating disease activity and progression as well as malignancy.
Hepatic iron content is a known risk factor for developing
hepatocellular carcinoma (HCC). While the association between
grades of siderotic dysplastic nodules and malignancy has not been
established, siderotic dysplastic nodules are thought to represent
premalignant lesions [15,16,20,21]. MRI has been used to grade
siderotic nodules, and nodule grade and number have been shown
to be significantly correlated with periportal inflammatory activity
in cirrhotic patients [33]. The distribution of iron and of siderotic
nodules within the liver can enhance HCC detection; regions of
hepatic parenchyma with a relative paucity of iron or siderotic
nodules sparing are more likely to contain HCC [34]. The pattern
of iron distribution within nodule can improve the detection of
HCC; decreased iron content within an otherwise siderotic nodule
(referred to as a ‘‘nodule within a nodule’’) is highly likely to
represent HCC [16,24]. Therefore, improving the sensitivity of
iron detection and distribution within all types of hepatic nodules
could improve the ability to detect hepatocellular carcinoma and
disease activity. We speculate that percutaneous hepatic biopsy of
some indeterminate hepatic nodules may be obviated if a nodule
not definitively classified as siderotic on other imaging techniques
could be shown to be diffusely siderotic with more sensitive
imaging techniques such as SWI. Additionally, SWI may also be of
use to evaluate iron loading within hepatic parenchyma in diseases
of iron overload.
We are aware of several limitations in this study. While T2*
weighted imaging is the most common clinically used method to
Table 3. Siderotic Nodule (SN) Conspicuity Grading.
Score T1-weighted imaging T2-weighted imaging T2*-weighted imaging SWI
{
1 (weak) 17.560.7 29.562.1 6.560.7 0
2 (moderate) 362.8 561.4 27.560.7 660.7
3 (strong) 0 1.560.7 12604 0 61.4
The number of patients (mean for two readers 6 standard deviation) is listed.
{SWI: susceptibility-weighted imaging, a 2D-gradient echo based abdominal imaging technique.
doi:10.1371/journal.pone.0036454.t003
Figure 3. Conspicuity grading of siderotic nodules by various magnetic resonance imaging techniques. Results indicate the mean
number (vertical axis, for both readers) of siderotic nodules (SN) and the relative conspicuity grade.
doi:10.1371/journal.pone.0036454.g003
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detection remains histologic; pathological correlation with explant
livers would be the ideal reference; lack of pathologic correlation
potentially biases results to favor T2* and SWI over other imaging
techniques. We also considered all hypointense lesions on T2* and
SWI to be siderotic nodules; while this is most likely given our
patient subset, other lesions can also appear hypointense. Only
histologic explant liver evaluation could definitively exclude all
possible nonsiderotic hypointense nodules. The inclusion of
patients only with known siderotic nodules introduces a bias,
and our evaluation cannot conclusively prove whether SWI would
detect siderotic nodules in instances where other MRI imaging
methods would detect none; T2* weighted MRI detected at least 5
or more siderotic nodules in all patients. Since only a single
representative image from each examination was chosen for
evaluation, the potential for undersampling bias exists; evaluation
of the entire hepatic volume would have eliminated this possible
bias. The use of multiple breath-hold imaging acquisitions to
achieve coverage of the entire liver may be difficult or unattainable
in some cirrhotic patients, such as those with ascites or reduced
pulmonary function. Gastrointestinal air is a known source of
magnetic susceptibility and can impart artifacts, and can limit
evaluation of some liver regions depending upon anatomic
considerations; however, we anticipated that further technological
improvements in MR sequence design can minimize such artifacts.
In conclusion, we show in this study that imaging using SWI
substantially improves both the conspicuity of siderotic nodules
and number of detected nodules relative to other techniques,
including T2*-weighted gradient-echo imaging; additionally, these
results are repeatable as inter-reader agreement is highly
correlated. SWI should be a useful addition to current imaging
techniques, and may prove to be the most sensitive technique for
the detection and characterization of hepatic siderotic nodules in
the future.
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